98 related articles for article (PubMed ID: 14720439)
1. [Analysis of caspases activity of hematopoietic progenitor cells and its significance in myelodysplastic syndromes].
Chen JL; Xu M; Song XZ; Li Q; Li RS
Zhonghua Xue Ye Xue Za Zhi; 2003 Nov; 24(11):565-7. PubMed ID: 14720439
[TBL] [Abstract][Full Text] [Related]
2. Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro.
Bouscary D; Chen YL; Guesnu M; Picard F; Viguier F; Lacombe C; Dreyfus F; Fontenay-Roupie M
Exp Hematol; 2000 Jul; 28(7):784-91. PubMed ID: 10907640
[TBL] [Abstract][Full Text] [Related]
3. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
[TBL] [Abstract][Full Text] [Related]
4. Expression and activity of caspases 1 and 3 in myelodysplastic syndromes.
Boudard D; Sordet O; Vasselon C; Revol V; Berthéas MF; Freyssenet D; Viallet A; Piselli S; Guyotat D; Campos L
Leukemia; 2000 Dec; 14(12):2045-51. PubMed ID: 11187891
[TBL] [Abstract][Full Text] [Related]
5. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
Zhang Z; Xie J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
[TBL] [Abstract][Full Text] [Related]
6. Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes.
Mundle SD; Reza S; Ali A; Mativi Y; Shetty V; Venugopal P; Gregory SA; Raza A
Cancer Lett; 1999 Jun; 140(1-2):201-7. PubMed ID: 10403560
[TBL] [Abstract][Full Text] [Related]
7. Sequential activation of caspase-1 and caspase-3-like proteases during apoptosis in myelodysplastic syndromes.
Ali A; Mundle SD; Ragasa D; Reza S; Shetty V; Mativi BY; Cartlidge JD; Azharuddin M; Qawi H; Dar S; Raza A
J Hematother Stem Cell Res; 1999 Aug; 8(4):343-56. PubMed ID: 10634172
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
[TBL] [Abstract][Full Text] [Related]
9. The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows.
Mundle S; Venugopal P; Shetty V; Ali A; Chopra H; Handa H; Rose S; Mativi BY; Gregory SA; Preisler HD; Raza A
Int J Hematol; 1999 Apr; 69(3):152-9. PubMed ID: 10222652
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
Mundle SD; Mativi BY; Bagai K; Feldman G; Cheema P; Gautam U; Reza S; Cartlidge JD; Venugopal P; Shetty V; Gregory SA; Robin E; Rifkin S; Shah R; Raza A
Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of arsenic trioxide induced tumor cell apoptosis in myelodysplastic syndrome mice model in vivo].
Lu J; Jin J
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):782-6. PubMed ID: 17229386
[TBL] [Abstract][Full Text] [Related]
12. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia.
Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L
Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of apoptosis protein inhibitor survivin and XIAP, in patients with myelodysplastic syndromes and in the cell line MUTZ-1].
Cai Z; Bao HY; Ludwig WD; Wuchter C
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):26-30. PubMed ID: 14990073
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS).
Economopoulou C; Pappa V; Papageorgiou S; Kontsioti F; Economopoulou P; Charitidou E; Girkas K; Kapsimali V; Papasteriadi C; Tsirigotis P; Papageorgiou E; Dervenoulas J; Economopoulos T
Ann Hematol; 2010 Apr; 89(4):349-58. PubMed ID: 19813013
[TBL] [Abstract][Full Text] [Related]
15. Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome.
Lin CW; Manshouri T; Jilani I; Neuberg D; Patel K; Kantarjian H; Andreeff M; Estrov Z; Beran M; Keating M; Estey E; Albitar M
Leuk Res; 2002 Jun; 26(6):551-9. PubMed ID: 12007503
[TBL] [Abstract][Full Text] [Related]
16. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
Ghaddar HM; Stass SA; Pierce S; Estey EH
Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
[TBL] [Abstract][Full Text] [Related]
18. Artesunate induces apoptosis through caspase-dependent and -independent mitochondrial pathways in human myelodysplastic syndrome SKM-1 cells.
Wang Y; Yang J; Chen L; Wang J; Wang Y; Luo J; Pan L; Zhang X
Chem Biol Interact; 2014 Aug; 219():28-36. PubMed ID: 24704559
[TBL] [Abstract][Full Text] [Related]
19. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
[TBL] [Abstract][Full Text] [Related]
20. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]